Neurocrine Biosciences
Neurocrine reports positive phase 3 data for hyperplasia drug in children
Anika Sharma
Just a month after the successful outcome of Neurocrine Biosciences’ phase 3 study for crinecerfont in adults with hyperplasia, the ...
Neurocrine advances potential blockbuster drug for endometrial hyperplasia after phase 3 success
Anika Sharma
Neurocrine Biosciences is banking on its hyperplasia drug, crinecerfont, which analysts predict could be a blockbuster. The company has been ...
FDA Approves Ingrezza (valbenazine) Capsules to Treat Chorea in Huntington’s Disease
Anika Sharma
Neurocrine Biosciences has achieved a significant milestone with the announcement of US Food and Drug Administration (FDA) approval for Ingrezza ...
